Importantly, two anti-depressants, amitriptyline (97) and ketamine (98), could respectively reduce NLRP3 and NK-FB expressive, and consequentially, inflammatory cytokine production in peripheral blood cells from MDD subjects. Here, NLRP3 is linked to major depressive disorder.